United Kingdom · Question · Written question
UIN 56571
Selective Serotonin Reuptake Inhibitors: Sexual Dysfunction
Original
Introduced
2 June 2025
Last action
5 June 2025 · Answer
Status
Answered
Sponsors
—
Subjects
Discovery layer
Source updated
5 June 2025
Summary
To ask the Secretary of State for Health and Social Care, pursuant to the Answer of 13 May 2025 to Question 50758 on Selective Serotonin Reuptake Inhibitors: Sexual Dysfunction, which regulatory options are under consideration; and what his planned timefr
This text is taken from the official record. PoliticalRepo does not editorialize.
Timeline
2 June 2025
Written question
To ask the Secretary of State for Health and Social Care, pursuant to the Answer of 13 May 2025 to Question 50758 on Selective Serotonin Reuptake Inhibitors: Sexual Dysfunction, which regulatory options are under consideration; and what his planned timefr
Source: Commons
5 June 2025
Answer
Following the next meeting of the Expert Working group (EWG), the Medicines and Healthcare products Regulatory Agency (MHRA) will seek advice from the Commission on Human Medicines on the recommendations of the EWG, on a wide range of regulatory options f...
Source: Written answer
Votes
No vote records are attached yet.
Versions
No version snapshots stored. Document URLs remain at the source.
Documents
No documents linked.
Sponsors
- · Department of Health and Social Care · Answering body
Related records
No cross-record relationships stored yet.
Sources
PoliticalRepo is an index and interpretation layer, not the authoritative legal source.
- Official source: https://questions-statements.parliament.uk/written-questions/detail/2025-06-02/56571
- Open data entity: https://questions-statements-api.parliament.uk/api/writtenquestions/questions/1808301
- uk · wq-1808301 · source updated 5 June 2025